Genes News and Research

RSS

New EcoTyper tool can help identify cancer subtypes

Researchers at the Stanford Institute for Stem Cell Biology and Regenerative Medicine have devised a tool to examine how cells behave and interact in various environments of the body.

30 Oct 2021

Two new studies show how to enhance effectiveness of cancer immunotherapy

Two new studies revealed that anti-PD-1 immunotherapy given before surgery was safe and effective for patients with oral-cavity squamous cell carcinoma (OCSCC) and identified potential molecular biomarkers in the blood and tumors of patients that would show how likely it is that someone would respond to immunotherapy.

30 Oct 2021

Drug-like molecule can counteract the effects of mutated epigenetic regulators that drive cancers

A decade ago, genome sequencing revealed a big surprise: about 50 percent of human cancers are linked to mutations in what are known as epigenetic regulators, which control the activity of genes.

29 Oct 2021

Researchers develop eToeholds for safe, effective RNA and cellular therapies

RNAs are best known as the molecules that translate information encoded in genes into proteins with their myriad of activities.

29 Oct 2021

The role of CRISPR in viral diagnostics

A comprehensive review explains in depth how CRISPR can be utilized as a reliable tool to investigate the viral life cycles.

29 Oct 2021

Scientists uncover key genetic networks governing human embryonic stem cell behavior

At the earliest stages of human embryonic development, a small collection of cells known as human embryonic stem cells (hESCs) orchestrates growth and differentiation, eventually giving rise to highly specialized human tissues.

28 Oct 2021

Penn's newly created split-engineered base editors show potential for research, therapeutics

Targeted mutations to the genome can now be introduced by splitting specific mutator enzymes and then triggering them to reconstitute, according to research from the Perelman School of Medicine at the University of Pennsylvania.

28 Oct 2021

Study unravels how cells protect against influenza A viruses

Human cells use a protein named TBC1D5 to route influenza A viruses inside host cells for destruction, preventing the virus from spreading replicated copies of itself to other cells, according to a study published in Nature Microbiology.

28 Oct 2021

How long does natural or vaccine-induced immunity to COVID last?

Researchers present a comprehensive assessment on SARS-CoV-2 induced immunity.

28 Oct 2021

A new approach to selectively turn on gene therapies in target cells

Researchers at MIT and Harvard University have designed a way to selectively turn on gene therapies in target cells, including human cells.

28 Oct 2021

New insight into the tremendously complex "genetic dance"

The rapid scientific advancements that followed the mapping of the human genome have revealed just how staggeringly complex the world of genetics is.

28 Oct 2021

Researchers discover genetic risk variants involved in osteoarthritis

Osteoarthritis is the leading cause of pain and disability worldwide. There is no cure, only pain relief. Patients' joints become inflamed, and they feel creaky and stiff in the morning.

28 Oct 2021

Panel of broadly neutralizing SARS-CoV-2 nanobodies for immune assay application

In this study, a team of researchers from Japanese institutions provide a panel of broadly neutralizing nanobodies that detect four VOCs.

28 Oct 2021

Chlorophyll catabolite pheophorbide A shows potential against SARS-CoV-2

A new study identifies a potent SARS-CoV-2 antiviral, Pheophorbide a (PheoA), which is a compound derived from the plant Marchantia polymorpha L.

27 Oct 2021

Modulating glycogen metabolism in fat cells may offer new approaches for weight loss

Humans carry around with them, often abundantly so, at least two kinds of fat tissue: white and brown. White fat cells are essentially inert containers for energy stored in the form of a single large, oily droplet.

27 Oct 2021

$9 million grant from ASAP initiative to help advance research on Parkinson’s disease treatments

Researchers around the world have tried many ways, and for many years, to generate neurons in the lab so they could study them better. Neurons-on-demand might also provide a therapeutic option for replacing neurons lost in neurodegenerative conditions, such as Parkinson's disease.

27 Oct 2021

Genes News and Research

New EcoTyper tool can help identify cancer subtypes

Two new studies show how to enhance effectiveness of cancer immunotherapy

Drug-like molecule can counteract the effects of mutated epigenetic regulators that drive cancers

Researchers develop eToeholds for safe, effective RNA and cellular therapies

The role of CRISPR in viral diagnostics

Scientists uncover key genetic networks governing human embryonic stem cell behavior

Penn's newly created split-engineered base editors show potential for research, therapeutics

Study unravels how cells protect against influenza A viruses

How long does natural or vaccine-induced immunity to COVID last?

A new approach to selectively turn on gene therapies in target cells

New insight into the tremendously complex "genetic dance"

Researchers discover genetic risk variants involved in osteoarthritis

Panel of broadly neutralizing SARS-CoV-2 nanobodies for immune assay application

Chlorophyll catabolite pheophorbide A shows potential against SARS-CoV-2

Modulating glycogen metabolism in fat cells may offer new approaches for weight loss

$9 million grant from ASAP initiative to help advance research on Parkinson’s disease treatments

Research reveals the microbial landscape of patients with systemic lupus erythematosus

Genetic factors influence moral views concerning drug use and noncommittal sex

Mapping C. difficile: Advanced ribotyping technology helps researchers keep track of deadly disease

Salk scientists find a way that neurons and astrocytes work together to form healthy synapses

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo